LISA CAMPBELL: Open Payments
NPI 1679228332 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 20 payments from 3 companies in 2025. Trend: 2023 $305 · 2024 $770 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $364 |
| REVANCE THERAPEUTICS, INC. | 3 | $118 |
| MERZ NORTH AMERICA, INC. | 2 | $64 |
Products named: DYSPORT, DAXXIFY, Xeomin, NEMLUVIO.
Industry payments across DE — which companies pay providers there.
